-
Protein production
Fundamental and advanced methods to improve monoclonal antibody production in vitro
Ever since the discovery of the hybridoma technology and its inherent limitations, monoclonal antibody production has gradually shifted from hybridoma-based in vivo methods towards recombinant-based in vitro methods. Today,…
-
Antibody production
How are mouse monoclonal antibodies humanized: current approaches and limitations
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Antibody production
Phage Display vs. Hybridoma: Choosing the Right Method for Monoclonal Antibody Production
Read more -
Antibody production
The best CHO expression system kits on the market
Read more -
Peptide synthesis
Are peptide vaccines providing a safer and more cost-effective alternative to conventional vaccines in protecting against life-threatening and chronic diseases?
Read more
-
Blog
Which approach should you choose to get a species-specific veterinary monoclonal antibody? A decision guide
Read more -
Customers success stories
Next-Generation Antibody Discovery Enabled By NativeMP™ and Phage Display Technology
Read more -
Customers success stories
Accelerating Translational Research: How Phage Display Technology Delivered High-Affinity Antibodies for Groundbreaking Applications
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Customers success stories
The Path of Creating an Innovative IL-17A Antibody for Autoimmune Disorders
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more